Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis

Infection and Immunity

Volumn 75, Issue 11, 2007, Pages 5105-5117

  Leonhardt, Ralf M ^a   Lee, Seung Joon ^a,b   Kavathas, Paula B ^a   Cresswell, Peter ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Kangwon National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN;

ARTICLE; BACTERIAL INFECTION; BACTERIAL SURVIVAL; CELL VACUOLE; CHLAMYDIA TRACHOMATIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; INNATE IMMUNITY; INTERNALIZATION; LIFE CYCLE; LYSOSOME; MICROTUBULE ORGANIZING CENTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

CHLAMYDIA TRACHOMATIS; CYTOPLASM; GENE EXPRESSION; HELA CELLS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; MICROTUBULE-ORGANIZING CENTER; RNA, BACTERIAL; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRYPTOPHAN; VIRULENCE;

EID: 35648952731     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00668-07     Document Type: Article

References (36)

1. Akers, J. C., and M. Tan. 2006. Molecular mechanism of tryptophan-dependent transcriptional regulation in Chlamydia trachomatis. J. Bacteriol. 188: 4236-4243.
2. Beatty, W. L., T. A. Belanger, A. A. Desai, R. P. Morrison, and G. I. Byrne. 1994. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect. Immun. 62:3705-3711.
3. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1993. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. USA 90:3998-4002.
4. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1994. Immunoelectron microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection. Infect. Immun. 62:4059-4062.
5. Belland, R. J., D. E. Nelson, D. Virok, D. D. Crane, D. Hogan, D. Sturdevant, W. L. Beatty, and H. D. Caldwell. 2003. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc. Natl. Acad. Sci. USA 100:15971-15976.
6. Bilenki, L., S. Wang, J. Yang, Y. Fan, A. G. Joyee, and X. Yang. 2005. NK T cell activation promotes Chlamydia trachomatis infection in vivo. J. Immunol. 175:3197-3206.
7. Brunham, R. C., and J. Rey-Ladino. 2005. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5:149-161.
8. Caldwell, H. D., H. Wood, D. Crane, R. Bailey, R. B. Jones, D. Mabey, I. Maclean, Z. Mohammed, R. Peeling, C. Roshick, J. Schachter, A. W. Solomon, W. E. Stamm, R. J. Suchland, L. Taylor, S. K. West, T. C. Quinn, R. J. Belland, and G. McClarty. 2003. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Investig. 111:1757-1769.
9. Centers for Disease Control and Prevention. 2006. Sexually transmitted disease surveillance 2005 supplement. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA.
10. Deka, S., J. Vanover, S. Dessus-Babus, J. Whittimore, M. K. Howett, P. B. Wyrick, and R. V. Schoborg. 2006. Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells. Cell. Microbiol. 8:149-162.
11. Fujigaki, S., K. Saito, M. Takemura, N. Maekawa, Y. Yamada, H. Wada, and M. Seishima. 2002. L-Tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect. Immun. 70:779-786.
12. Gieffers, J., J. Rupp, A. Gebert, W. Solbach, and M. Klinger. 2004. First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae. Antimicrob. Agents Chemother. 48:1402-1405.
13. Goellner, S., E. Schubert, E. Liebler-Tenorio, H. Hotzel, H. P. Saluz, and K. Sachse. 2006. Transcriptional response patterns of Chlamydophila psittaci in different in vitro models of persistent infection. Infect. Immun. 74:4801-4808.
14. Grieshaber, S. S., N. A. Grieshaber, and T. Hackstadt. 2003. Chlamydia trachomatis uses host cell dynein to traffic to the microtubule-organizing center in a p50 dynamitin-independent process. J. Cell Sci. 116:3793-3802.
15. Harper, A., C. I. Pogson, M. L. Jones, and J. H. Pearce. 2000. Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect. Immun. 68:1457-1464.
16. Hogan, R. J., S. A. Mathews, S. Mukhopadhyay, J. T. Summersgill, and P. Timms. 2004. Chlamydial persistence: beyond the biphasic paradigm. Infect. Immun. 72:1843-1855.
17. Hsia, R., H. Ohayon, P. Gounon, A. Dautry-Varsat, and P. M. Bavoil. 2000. Phage infection of the obligate intracellular bacterium, Chlamydia psittaci strain guinea pig inclusion conjunctivitis. Microbes Infect. 2:761-772.
18. Johnson, F. W., and D. Hobson. 1977. The effect of penicillin on genital strains of Chlamydia trachomatis in tissue culture. J. Antimicrob. Chemother. 3:49-56.
19. Kahane, S., and M. G. Friedman. 1992. Reversibility of heat shock in Chlamydia trachomatis. FEMS Microbiol. Lett. 76:25-30.
20. Klassen, P., P. Furst, C. Schulz, M. Mazariegos, and N. W. Solomons. 2001. Plasma free amino acid concentrations in healthy Guatemalan adults and in patients with classic dengue. Am. J. Clin. Nutr. 73:647-652.
21. Kudo, Y., C. A. Boyd, I. L. Sargent, and C. W. Redman. 2001. Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J. Physiol. 535:207-215.
22. Mabey, D., and R. W. Peeling. 2002. Lymphogranuloma venereum. Sex. Transm. Infect. 78:90-92.
23. Ouellette, S. P., T. P. Hatch, Y. M. AbdelRahman, L. A. Rose, R. J. Belland, and G. I. Byrne. 2006. Global transcriptional upregulation in the absence of increased translation in Chlamydia during IFNγ-mediated host cell tryptophan starvation. Mol. Microbiol. 62:1387-1401.
24. Palacin, M., R. Estevez, J. Bertran, and A. Zorzano. 1998. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol. Rev. 78:969-1054.
25. Ritchie, J. W., and P. M. Taylor. 2001. Role of the system L permease LAT1 in amino acid and iodothyronine transport in placenta. Biochem. J. 356:719-725.
26. + T cells respond to Chlamydia trachomatis in the genital mucosa. J. Immunol. 177: 7974-7979.
27. Roshick, C., H. Wood, H. D. Caldwell, and G. McClarty. 2006. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect. Immun. 74:225-238.
28. Scidmore, M. A., E. R. Fischer, and T. Hackstadt. 2003. Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Infect. Immun. 71:973-984.
29. Scidmore, M. A., D. D. Rockey, E. R. Fischer, R. A. Heinzen, and T. Hackstadt. 1996. Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry. Infect. Immun. 64:5366-5372.
30. Scidmore-Carlson, M. A., E. I. Shaw, C. A. Dooley, E. R. Fischer, and T. Hackstadt. 1999. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol. Microbiol. 33:753-765.
31. Seymour, R. L., V. Ganapathy, A. L. Mellor, and D. H. Munn. 2006. A high-affinity, tryptophan-selective amino acid transport system in human macrophages. J. Leukoc. Biol. 80:1320-1327.
32. Shennan, D. B., J. Thomson, M. C. Barber, and M. T. Travers. 2003. Functional and molecular characteristics of system L in human breast cancer cells. Biochim. Biophys. Acta 1611:81-90.
33. Wagenlehner, F. M., K. G. Naber, and W. Weidner. 2006. Chlamydial infections and prostatitis in men. BJU Int. 97:687-690.
34. Werner, E. R., M. Hirsch-Kauffmann, D. Fuchs, A. Hausen, G. Reibnegger, M. Schweiger, and H. Wachter. 1987. Interferon-gamma-induced degradation of tryptophan by human cells in vitro. Biol. Chem. Hoppe-Seyler 368: 1407-1412.
35. Wolf, K., H. J. Betts, B. Chellas-Gery, S. Hower, C. N. Linton, and K. A. Fields. 2006. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61:1543-1555.
36. Xie, G., C. A. Bonner, and R. A. Jensen. 2002. Dynamic diversity of the tryptophan pathway in chlamydiae: reductive evolution and a novel operon for tryptophan recapture. Genome Biol 3:research0051.